About the complexity of adult onset Still's disease... and advances still required for its management

BMC Medicine

Volumn 15, Issue 1, 2017, Pages

  Guilpain, Philippe ^a,b   Le Quellec, Alain ^a  

^a UNIV MONTPELLIER   (France)

^b HÔPITAL SAINT ELOI   (France)

Author keywords

Adult onset Still's disease; Cytokine; Diagnosis; Inflammasome; Macrophage activation syndrome; Prognosis; Score; Therapy

Indexed keywords

BIOLOGICAL PRODUCT; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; TOLL LIKE RECEPTOR; CYTOKINE;

ADULT ONSET STILL DISEASE; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; HUMAN; INFLAMMATION; INNATE IMMUNITY; LONG TERM CARE; MACROPHAGE ACTIVATION SYNDROME; MORTALITY; NOTE; PATHOPHYSIOLOGY; PROGNOSIS; RECEPTOR UPREGULATION; ADAPTIVE IMMUNITY; ADULT; BIOLOGICAL THERAPY; PROCEDURES;

ADAPTIVE IMMUNITY; ADULT; BIOLOGICAL THERAPY; CYTOKINES; HUMANS; PROGNOSIS; STILL'S DISEASE, ADULT-ONSET;

EID: 85010203605     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-016-0769-1     Document Type: Note

References (17)

1. Maria ATJ, Le Quellec A, Jorgensen C, Touitou I, Rivière S, Guilpain P. Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions. Autoimmun Rev. 2014;13:1149-59.
2. Ruscitti P, Cipriani P, Masedu F, Iacono D, Ciccia F, Liakouli V, Guggino G, Carubbi F, Berardicurti O, Di Benedetto P, Valenti M, Triolo G, Valentini G, Giacomelli R. Adult onset Still's disease: evaluation of prognostic tools and validation of the systemic score, by analysis of 100 cases from three centers. BMC Med. 2016;14:194.
3. Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol. 1992;19:424-30.
4. Fautrel B, Zing E, Golmard J-L, Le Moel G, Bissery A, Rioux C, et al. Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore). 2002;81:194-200.
5. Pouchot J, Sampalis JS, Beaudet F, Carette S, Décary F, Salusinsky-Sternbach M, et al. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore). 1991;70:118-36.
6. Reginato AJ, Schumacher HR, Baker DG, O'Connor CR, Ferreiros J. Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failure. Semin Arthritis Rheum. 1987;17:39-57.
7. Sampalis JS, Esdaile JM, Medsger TA, Partridge AJ, Yeadon C, Senécal JL, et al. A controlled study of the long-term prognosis of adult Still's disease. Am J Med. 1995;98:384-8.
8. Arlet J-B, Le THD, Marinho A, Amoura Z, Wechsler B, Papo T, et al. Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature. Ann Rheum Dis. 2006;65:1596-601.
9. Cush JJ, Medsger TA, Christy WC, Herbert DC, Cooperstein LA. Adult-onset Still's disease. Clinical course and outcome. Arthritis Rheum. 1987;30:186-94.
10. Wouters JM, van de Putte LB. Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases. Q J Med. 1986;61:1055-65.
11. Medsger TA, Christy WC. Carpal arthritis with ankylosis in late onset Still's disease. Arthritis Rheum. 1976;19:232-42.
12. Kong X-D, Xu D, Zhang W, Zhao Y, Zeng X, Zhang F. Clinical features and prognosis in adult-onset Still's disease: a study of 104 cases. Clin Rheumatol. 2010;29:1015-9.
13. Zeng T, Zou Y-Q, Wu M-F, Yang C-D. Clinical features and prognosis of adult-onset still's disease: 61 cases from China. J Rheumatol. 2009;36:1026-31.
14. Lee S-W, Park Y-B, Song J-S, Lee S-K. The mid-range of the adjusted level of ferritin can predict the chronic course in patients with adult onset Still's disease. J Rheumatol. 2009;36:156-62.
15. Bae C-B, Jung J-Y, Kim H-A, Suh C-H. Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patients. Medicine (Baltimore). 2015;94:e451.
16. Fukaya S, Yasuda S, Hashimoto T, Oku K, Kataoka H, Horita T, et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology. 2008;47:1686-91.
17. Kumakura S, Murakawa Y. Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults. Arthritis Rheumatol. 2014;66:2297-307.